Three studies with 190 subjects investigated the relationship between SNHG12 expression and disease-free survival (DFS) in patients with GC, LSCC, and DLBCL [13, 19, 32]. This evidence concerns the gene SNHG12 and diffuse large B-cell lymphoma.